Nuvectis Pharma, Inc. Common Stock

NVCT XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

250M

Short interest (May 15)

5.4%

Net Short (Jun 03 ): 0.0%

Borrow Fee

1.11%

↓ 8.7%

Available Shares

80K

↓ 36.0%

Price Chart

Company Overview

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001875558

Asset Type: CS

Market Data

Market Cap: $252,257,818

Employees: 13

Status: Active

Short Interest

Current Borrow Fee 1.11%

Range: 1.09% - 1.19%

Available Shares 80K

Range: 15K - 80K

Recent Changes

Fee Change: ↓ 5.6%

Available Change: ↑ 30.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime